✦ LIBER ✦

Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention

✍ Scribed by Atsuko Nakayama, Hiroyuki Morita, Jiro Ando, Hideo Fujita…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of Adverse Outcomes in Taiwan Assoc

✍ Chin-Chou Huang; Yu-Chun Chen; Hsin-Bang Leu; Tzeng-Ji Chen; Shing-Jong Lin; Wan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Cardiovascular outcomes associated with

✍ Lin, Chen-Fang; Shen, Li-Jiuan; Wu, Fe-Lin Lin; Bai, Chyi-Huey; Gau, Churn-Shiou 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 949 KB

PCV6 Risk of Adverse Cardiovascular Outc

✍ R. Mahabaleshwarkar; Y. Yang; M. Datar; J.P. Bentley; M. Strum; B.F.I. Banahan; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Association of the use of proton pump in

✍ Takeshi Kimura; Takeshi Morimoto; Yutaka Furukawa; Yoshihisa Nakagawa; Kazushige 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 452 KB

Concomitant use of clopidogrel and proto

✍ M. Schmidt; M. B. Johansen; D. J. Robertson; M. Maeng; A. Kaltoft; L. O. Jensen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Clinical Outcomes Associated with Concom

✍ C. Liew; C. Hiew; O. Narayan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB